High Tech Pharm Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for High Tech Pharm.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	31.9%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)

Oct 23

Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?

Aug 06

Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%

Jul 02

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

May 09

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

Dec 15

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as High Tech Pharm has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A106190 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	81,558	14,558	8,712	11,163	N/A
6/30/2024	83,502	13,522	3,075	6,791	N/A
3/31/2024	82,545	11,596	8,871	13,678	N/A
12/31/2023	76,772	8,076	-2,183	2,909	N/A
9/30/2023	79,175	8,114	43	4,862	N/A
6/30/2023	94,102	7,931	3,207	6,159	N/A
3/31/2023	102,150	6,799	2,574	4,034	N/A
12/31/2022	102,947	5,873	-4,359	-3,703	N/A
9/30/2022	88,688	5	2,500	2,834	N/A
6/30/2022	70,212	-1,205	-5,808	-5,020	N/A
3/31/2022	67,869	-2,977	-3,475	-2,615	N/A
12/31/2021	73,287	-1,225	6,068	6,928	N/A
9/30/2021	79,120	-1,054	-6,260	-5,124	N/A
6/30/2021	85,343	-367	-3,739	-3,289	N/A
3/31/2021	79,496	-2,535	-5,737	-4,921	N/A
12/31/2020	74,462	-3,152	-8,628	-7,691	N/A
9/30/2020	72,142	-5,630	-5,701	-4,966	N/A
6/30/2020	73,147	-7,340	-588	131	N/A
3/31/2020	67,977	-4,743	-2,416	-1,292	N/A
12/31/2019	63,068	-4,218	327	2,484	N/A
9/30/2019	61,495	-917	-5,540	-3,199	N/A
6/30/2019	54,381	1,116	-5,468	509	N/A
3/31/2019	60,013	2,413	-4,231	3,574	N/A
12/31/2018	66,388	2,608	-3,583	5,379	N/A
9/30/2018	69,853	2,711	-304	10,853	N/A
6/30/2018	70,430	2,863	N/A	9,507	N/A
3/31/2018	67,593	2,640	N/A	10,103	N/A
12/31/2017	66,050	2,100	N/A	5,452	N/A
9/30/2017	65,534	4,866	N/A	3,572	N/A
6/30/2017	58,847	3,514	N/A	-95	N/A
3/31/2017	54,081	4,449	N/A	-366	N/A
12/31/2016	54,836	5,280	N/A	1,448	N/A
9/30/2016	50,660	3,024	N/A	3,178	N/A
6/30/2016	53,373	5,400	N/A	4,446	N/A
3/31/2016	53,452	6,263	N/A	7,419	N/A
12/31/2015	48,092	6,544	N/A	12,709	N/A
9/30/2015	47,604	8,613	N/A	13,701	N/A
6/30/2015	45,844	9,079	N/A	17,227	N/A
3/31/2015	49,264	7,038	N/A	13,997	N/A
12/31/2014	56,897	7,835	N/A	10,173	N/A
9/30/2014	58,740	6,651	N/A	14,917	N/A
6/30/2014	64,722	5,597	N/A	9,618	N/A
3/31/2014	68,248	9,260	N/A	9,152	N/A
12/31/2013	65,183	10,455	N/A	6,408	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A106190's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A106190's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A106190's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A106190's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A106190's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A106190's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 11:48
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

High Tech Pharm Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

High Tech Pharm Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Upcoming dividend of ₩66.67 per share

New minor risk - Market cap size

Third quarter 2024 earnings released: EPS: ₩223 (vs ₩126 in 3Q 2023)

A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)

Now 21% undervalued after recent price drop

Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?

Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

Investor sentiment improves as stock rises 15%

Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?

Inaugural dividend of ₩70.00 per share

Investor sentiment improves as stock rises 15%

Upcoming dividend of ₩50.00 per share

No independent directors

No independent directors

Inaugural dividend of ₩50.00 per share

Third quarter 2021 earnings released: ₩8.00 loss per share (vs ₩89.00 profit in 3Q 2020)

First quarter 2021 earnings released: EPS ₩64.00 (vs ₩7.00 loss in 1Q 2020)

We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt

Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?

New 90-day high: ₩26,350

New 90-day high: ₩20,150

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

New 90-day high: ₩15,200

Third quarter 2020 earnings released: EPS ₩89.00

New 90-day high - ₩14,200

New 90-day high - ₩12,100

New 90-day high - ₩11,400